The average molecular weight (Mw) should be 27500-39500. Its osmotic pressure is equal to that of plasma, which can maintain the balance between intravascular fluid and interstitial fluid, does not cause tissue dehydration and pulmonary edema, and has the effect of maintaining blood volume and raising blood pressure. Infusion of this product can lead to blood dilution, reduce blood viscosity, and thus improve microcirculation. This product has no significant effect on blood clotting time and platelet function, and only has a blood dilution effect.

The average molecular weight is 27500-39500, and the osmotic pressure is equal to that of plasma. It can maintain the balance between intravascular fluid and interstitial fluid, does not cause tissue dehydration and pulmonary edema, and has the function of maintaining blood volume and raising blood pressure. After infusion, it can lead to blood dilution, reduce blood viscosity, and improve microcirculation. It has no obvious effect on blood clotting time and platelet function, and only has a blood dilution effect.

This product is a vasodilator that can improve blood rheology and reduce peripheral vascular resistance. This product can promote glucose to pass through the blood-brain barrier, enhance the utilization of glucose and oxygen in brain cells, and improve brain sugar metabolism and brain function.

Fructose injection is an energy and fluid supplement. Fructose is easier to form glycogen than glucose, and is mainly metabolized in the liver through fructokinase. It is easily metabolized into lactic acid and quickly converted into energy.

A broad-spectrum quinolone antibacterial agent. It has strong bactericidal activity against Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. In vivo antibacterial efficacy tests in animal infection models show that this product is superior to norfloxacin and enoxacin.